HMGB1 and Hepatic fibrosis: For example, Zhang et al. (2020) designed pPB peptide-modified, HMGB1 (high mobility group box 1)-siRNA (small interfering RNA) loaded nanoparticles to alleviate liver fibrosis by inhibiting the activation and proliferation of HSCs.